NASDAQ:EGRX
Eagle Pharmaceuticals, Inc.
- Stock
Last Close
1.96
01/05 20:00
Market Cap
78.44M
Beta: 0.91
Volume Today
470
Avg: 153.65K
PE Ratio
4.72
PFCF: −7.76
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | 2.57M - | 81.45M 3,068.14% | 51.94M 36.23% | 31.90M 38.58% | 14.31M 55.14% | 11.99M 16.24% | -8.63M 171.96% | 35.64M 513.14% | -2.67M 107.48% | |
depreciation and amortization | 112K - | 1.59M 1,318.75% | 3.75M 135.81% | 3.67M 2.05% | 4.65M 26.73% | 4.77M 2.47% | 3.76M 21.11% | 12.02M 219.79% | 16.67M 38.62% | |
deferred income tax | -3.78M - | -30.12M 697.14% | 17.29M 157.41% | -2.47M 114.27% | 152K 106.16% | -1.51M 1,094.08% | -3.62M 139.44% | -8.32M 130.07% | 29.93M 459.57% | |
stock based compensation | 4.05M - | 9.77M 141.13% | 15.43M 57.95% | 19.08M 23.68% | 22.00M 15.28% | 24.76M 12.54% | 19.55M 21.01% | 16.45M 15.87% | 16.80M 2.09% | |
change in working capital | -16.73M - | -8.69M 48.02% | -29.57M 240.11% | -7.89M 73.32% | 14.39M 282.43% | 816K 94.33% | 9.54M 1,068.75% | -16.40M 272.00% | 866K 105.28% | |
accounts receivables | -14.31M - | -15.92M 11.24% | -11.63M 26.96% | -12.66M 8.93% | 18.48M 245.92% | -3.11M 116.84% | 9.53M 406.10% | -30.83M 423.56% | ||
inventory | -13.80M - | 12.30M 189.15% | -2.38M 119.34% | -5.56M 133.54% | 1.74M 131.30% | -1.51M 186.77% | -13.83M 816.70% | -8.34M 39.72% | 866K 110.38% | |
accounts payables | 356K - | 10.67M 2,896.63% | -8.46M 179.30% | -2.06M 75.60% | -4.46M 115.84% | 806K 118.09% | 10.16M 1,160.79% | 2.97M 70.81% | ||
other working capital | 11.03M - | -15.75M 242.76% | -7.10M 54.89% | 12.40M 274.52% | -1.37M 111.08% | 4.63M 437.36% | 3.68M 20.57% | 19.80M 438.22% | -866K 104.37% | |
other non cash items | 4.05M - | -793K 119.58% | 80K 110.09% | 8.09M 10,007.50% | 480K 94.06% | 8.68M 1,708.54% | 7.61M 12.31% | 11.31M 48.61% | -30.80M 372.25% | |
net cash provided by operating activities | -9.72M - | 53.21M 647.51% | 58.92M 10.74% | 52.38M 11.09% | 55.99M 6.88% | 49.50M 11.59% | 28.22M 42.99% | 50.70M 79.67% | 30.80M 39.26% | |
investments in property plant and equipment | -1.88M - | -20.69M 999.95% | -5.19M 74.93% | -133K 97.44% | -777K 484.21% | -747K 3.86% | -323K 56.76% | -178K 44.89% | ||
acquisitions net | -26.86M - | -74.15M - | ||||||||
purchases of investments | -106.00M - | -62M 41.51% | -17.50M - | -12.50M - | ||||||
sales maturities of investments | 106.00M - | 62M 41.51% | 74.15M - | |||||||
other investing activites | 1.75M - | -5M - | -74.15M 1,383.04% | |||||||
net cash used for investing activites | -1.88M - | -45.80M 2,334.88% | -5.19M 88.68% | -133K 97.44% | -777K 484.21% | -18.25M 2,248.39% | -5.32M 70.83% | -86.83M 1,531.22% | ||
debt repayment | -1.25M - | -3.75M 200% | -6M 60% | -115M 1,816.67% | -8M 93.04% | -67.24M 740.45% | ||||
common stock issued | 54.33M - | 260K - | 3.65M 1,305.38% | 2.40M 34.37% | 1.75M 27.15% | |||||
common stock repurchased | -37.00M - | -43.79M 18.35% | -73.11M 66.94% | -17.96M 75.43% | -35.00M 94.86% | -21.21M 39.39% | -18.00M 15.13% | |||
dividends paid | -260K - | -3.65M 1,305.38% | -2.40M 34.37% | -1.75M 27.15% | ||||||
other financing activites | 1.48M - | 3.33M 124.90% | 53.15M 1,494.54% | -11.26M 121.19% | -264K 97.66% | 112.13M 42,573.11% | 821K 99.27% | 79.03M 9,526.19% | ||
net cash used provided by financing activities | 55.81M - | -33.67M 160.33% | 8.10M 124.07% | -88.12M 1,187.33% | -24.23M 72.51% | -37.87M 56.33% | -28.39M 25.03% | -6.21M 78.13% | ||
effect of forex changes on cash | ||||||||||
net change in cash | 44.21M - | -26.26M 159.40% | 61.84M 335.45% | -35.87M 158.00% | 30.98M 186.39% | -6.62M 121.37% | -5.50M 16.98% | -42.34M 670.34% | 30.80M 172.74% | |
cash at beginning of period | 34.87M - | 79.08M 126.80% | 52.82M 33.21% | 114.66M 117.07% | 78.79M 31.28% | 109.78M 39.32% | 103.16M 6.03% | 97.66M 5.33% | ||
cash at end of period | 79.08M - | 52.82M 33.21% | 114.66M 117.07% | 78.79M 31.28% | 109.78M 39.32% | 103.16M 6.03% | 97.66M 5.33% | 55.32M 43.35% | 30.80M 44.33% | |
operating cash flow | -9.72M - | 53.21M 647.51% | 58.92M 10.74% | 52.38M 11.09% | 55.99M 6.88% | 49.50M 11.59% | 28.22M 42.99% | 50.70M 79.67% | 30.80M 39.26% | |
capital expenditure | -1.88M - | -20.69M 999.95% | -5.19M 74.93% | -133K 97.44% | -777K 484.21% | -747K 3.86% | -323K 56.76% | -178K 44.89% | ||
free cash flow | -11.60M - | 32.52M 380.34% | 53.73M 65.25% | 52.25M 2.76% | 55.21M 5.66% | 48.75M 11.70% | 27.90M 42.78% | 50.52M 81.11% | 30.80M 39.04% |
All numbers in USD (except ratios and percentages)